Early Phase
Global Clinical Development
Late Phase
Biometrics
Medical & Regulatory Affairs
Resourcing Solutions
SERVICES Early Phase Global Clinical Development Late Phase Biometrics Medical & Regulatory Affairs Medical Affairs Regulatory Affairs Resourcing Solutions
Medical and Regulatory Affairs
The regulatory environments within the industry continue to change and vary internationally. Our regulatory and medical professionals keep track of the changes and anticipate developments globally.
We provide expertise either as an independent team or working alongside the client’s own management from early stage research through to product launch.
Chiltern’s contribution to projects can range from the strategic planning of critical paths to applying for clinical trial and marketing authorizations. We have extensive experience in providing due diligence programs and full pharmacovigilance services for licensed and unlicensed products.
The knowledge base within Chiltern’s Regulatory and Medical Affairs Team ensures that studies have consistent high standards of scientific and medical representation to meet the requirements of the relevant competent authorities. Customized seminars are also available to provide valuable training to client in-house teams.
For more information about our capabilities, please click on the links below.
We provide expertise either as an independent team or working alongside the client’s own management from early stage research through to product launch.
Chiltern’s contribution to projects can range from the strategic planning of critical paths to applying for clinical trial and marketing authorizations. We have extensive experience in providing due diligence programs and full pharmacovigilance services for licensed and unlicensed products.
The knowledge base within Chiltern’s Regulatory and Medical Affairs Team ensures that studies have consistent high standards of scientific and medical representation to meet the requirements of the relevant competent authorities. Customized seminars are also available to provide valuable training to client in-house teams.
For more information about our capabilities, please click on the links below.
In The Media
Chiltern Announces Its Financial Results For The Year Ended 31 March 2010, 27 July 2010 More
Follow the Project Leader, Chiltern Featured Article in the EPC June 2010 Issue , 30 June 2010 More
Chiltern Launches Collaborative Technologies, 10 June 2010 More
Chiltern Achieves Supplementary Accreditation from the Medicines and Healthcare products Regulatory Agency, 7 June 2010 More
Chiltern Announces Early Phase Partnership with Tayside Academic Health Sciences Centre, 2 June 2010 More

